Under 935 CMR 501.010(7), Massachusetts medical cannabis patients may possess up to a 60-day supply—defined as 10 ounces of cannabis flower or its concentrate/edible equivalent—on a rolling basis. This limit resets continuously, not on a fixed calendar date, meaning your allowable possession window refreshes from the date of each dispensary purchase. Patients who understand this mechanism can plan purchases strategically, maintain uninterrupted therapeutic access, and remain fully compliant with Cannabis Control Commission (CCC) regulations in 2026.

For patients managing chronic pain, anxiety, PTSD, or other debilitating conditions, running out of medicine mid-cycle is not merely inconvenient—it can destabilize carefully titrated therapeutic regimens. Understanding the rolling nature of the 60-day window means patients can time purchases to maintain continuous access rather than waiting for an arbitrary calendar reset that does not exist under Massachusetts law. Equally important is the financial dimension. Every ounce purchased under a valid medical registration is fully exempt from the combined state excise and local option taxes that adult-use consumers pay—a savings of 17–20% per transaction. Over a year of consistent use, that exemption can represent hundreds of dollars returned to patients who are already managing the costs of a chronic medical condition. Knowing your limit is the first step to using it wisely.

The Massachusetts 60-day rolling supply limit is a patient-protective provision, not a punitive restriction. It was designed to ensure registered patients have access to a clinically meaningful quantity of medicine while preventing diversion—and when patients understand how the rolling window actually functions, they gain both legal confidence and purchasing flexibility that fixed-calendar systems would not provide. My clinical advice is straightforward: know your purchase history, communicate openly with your dispensary’s patient care staff, and plan refills before you reach the bottom of your supply. The system is built to work for you. Pair that knowledge with a personalized therapeutic protocol—appropriate chemovar selection, dosing schedule, and route of administration—and the 60-day limit becomes a framework for consistent, safe, and cost-effective care rather than a bureaucratic obstacle.

Under 935 CMR 501.010(7), a Massachusetts registered patient may possess a 60-day supply of cannabis, defined as no more than 10 ounces of usable marijuana or its concentrate and edible equivalent. The word ‘rolling’ is critical: this is not a fixed bimonthly allotment that resets on a calendar date. It is a continuously moving 60-day window anchored to each patient’s individual purchase history.

In practice, this means a patient who purchases 4 ounces on January 1 and 6 ounces on January 15 has reached their 10-ounce ceiling. They may not purchase additional cannabis until the January 1 purchase falls outside the 60-day lookback window—around March 2—at which point 4 ounces of new capacity opens. Dispensary seed-to-sale software linked to MassCIP enforces this automatically at the point of sale.

The 10-ounce ceiling applies to all cannabis product forms, not just flower. The CCC uses established equivalency ratios: one ounce of flower is equivalent to 5 grams of concentrate (wax, shatter, live resin, distillate) or approximately 500 mg of THC in edible or tincture form. Patients who rely primarily on concentrates or capsules should calculate their purchases in flower-equivalent ounces to avoid inadvertently exceeding their limit.

A patient purchasing a 1-gram concentrate cartridge is consuming the equivalent of roughly 0.2 ounces of flower against their rolling limit. Ten such cartridges equal the full 10-ounce allotment. Mixed-product patients—those using flower, tinctures, and edibles simultaneously—should ask their dispensary’s patient care specialist to display their remaining rolling balance before each transaction, as MassCIP-integrated POS systems can provide this in real time.

Massachusetts dispensaries are required under 935 CMR 501.105 to use CCC-approved seed-to-sale tracking software that interfaces with the MassCIP patient registry. When a patient presents their medical cannabis card or temporary digital certificate at the counter, the system instantly queries their 60-day purchase history and calculates remaining allowable volume. Patients cannot exceed their limit at a licensed dispensary—the system will flag the transaction.

This real-time enforcement protects patients from accidental over-purchase and protects dispensaries from compliance violations. Patients who visit multiple dispensaries should be aware that all licensed Massachusetts retailers share the same statewide tracking database. There is no benefit—and significant legal risk—to attempting to split purchases across dispensaries to circumvent the rolling limit. The registry sees all transactions statewide.

Under 935 CMR 501.010, a registered personal caregiver may purchase cannabis on behalf of a registered patient. Critically, caregiver purchases count against the patient’s rolling 60-day supply—not against a separate caregiver allotment. A caregiver serving multiple patients maintains separate rolling limits for each patient they represent, and each patient’s 10-ounce ceiling applies independently.

Caregivers must present their CCC-issued caregiver registration card alongside the patient’s registry information at the dispensary. The seed-to-sale system logs the transaction against the patient’s MassCIP record. Caregivers who are also patients themselves maintain two separate rolling limits: one for their own medical use and one for each patient they serve. Meticulous record-keeping is strongly advised for caregivers managing multiple patients.

Every purchase made under a valid Massachusetts medical cannabis registration is fully exempt from the state’s 10.75% cannabis excise tax and the local option tax of up to 3%—a combined savings of 13.75–20% depending on municipality. On a $300 dispensary purchase, that exemption saves $41–$60 per transaction. Across a year of consistent medical use, the cumulative savings frequently exceed the cost of annual physician recertification.

Strategically, patients benefit from understanding their rolling window to avoid both under-purchasing (running out before the window refreshes) and over-purchasing (hitting the ceiling prematurely and losing flexibility). Patients with stable, predictable consumption patterns can map their ideal purchase schedule across the rolling 60-day window to maintain continuous supply while maximizing the tax exemption on every transaction. Your certifying physician can help you estimate a clinically appropriate monthly volume during your consultation.

Holding a Massachusetts medical cannabis registration and understanding your 60-day supply limit does not mean you are exempt from all cannabis-related legal exposure. Federal law still classifies cannabis as a Schedule I controlled substance as of early 2026, pending the outcome of the DEA rescheduling process. Possession on federal property, in federal housing, or across state lines remains a federal offense regardless of your Massachusetts medical status. Your medical card does not authorize cannabis use while operating a motor vehicle, in public spaces, or in any location where the property owner prohibits it. It does not replace emergency psychiatric or medical care, does not guarantee employment protection in all sectors, and does not permit you to purchase beyond your rolling limit regardless of medical necessity claims made at the dispensary counter.

The 60-day rolling supply limit sits within a broader national conversation about how state medical cannabis programs balance patient access against diversion prevention. Massachusetts has consistently positioned itself as a patient-forward state since the passage of Ballot Question 3 in 2012, and the rolling—rather than fixed-calendar—supply window reflects a deliberate policy choice to accommodate patients with variable consumption patterns rather than penalizing them for purchasing early in a calendar period.

From an integrative medicine perspective, the supply limit also implicitly encourages patients to engage with a certifying physician who can help them estimate appropriate therapeutic volumes, select suitable product forms, and monitor outcomes over time. Patients who understand their rolling limit are more likely to approach cannabis as a structured medical therapy rather than an unguided supplement—a distinction that meaningfully improves clinical outcomes and reduces the risk of overconsumption, tolerance escalation, and cannabinoid hyperemesis syndrome.

If you take one thing from this guide, let it be this: the Massachusetts 60-day rolling supply limit is a patient-protective, continuously moving window—not a fixed bimonthly calendar reset. Ten ounces of flower (or its concentrate and edible equivalent) is available to you across any 60-day period, tracked in real time by your dispensary’s state-integrated system. Understanding this mechanism lets you plan purchases confidently, maintain uninterrupted therapeutic access, and capture the full 17–20% tax exemption on every transaction. When in doubt, ask your dispensary’s patient care specialist to display your current rolling balance before you purchase—they are required to have that information available.